These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 30470994)
1. Impact of systemic inflammation biomarkers on the survival outcomes of cervical cancer patients. Holub K; Biete A Clin Transl Oncol; 2019 Jul; 21(7):836-844. PubMed ID: 30470994 [TBL] [Abstract][Full Text] [Related]
2. Unveiling the mechanisms of immune evasion in pancreatic cancer: may it be a systemic inflammation responsible for dismal survival? Holub K; Conill C Clin Transl Oncol; 2020 Jan; 22(1):81-90. PubMed ID: 31004253 [TBL] [Abstract][Full Text] [Related]
3. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab. Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096 [TBL] [Abstract][Full Text] [Related]
4. New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancer. Holub K; Biete A BMC Cancer; 2018 Dec; 18(1):1280. PubMed ID: 30577833 [TBL] [Abstract][Full Text] [Related]
5. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer. Al Jarroudi O; El Bairi K; Abda N; Zaimi A; Jaouani L; Chibani H; Afqir S Biomark Med; 2021 Oct; 15(14):1289-1298. PubMed ID: 34486882 [No Abstract] [Full Text] [Related]
6. Preoperative prognostic nutritional index and systemic immune-inflammation index predict survival outcomes in osteosarcoma: A comparison between young and elderly patients. Ma C; Yu R; Li J; Guo J; Xu J; Wang X; Liu P J Surg Oncol; 2022 Mar; 125(4):754-765. PubMed ID: 34811745 [TBL] [Abstract][Full Text] [Related]
7. Systemic inflammation scores correlate with survival prognosis in patients with newly diagnosed brain metastases. Starzer AM; Steindl A; Mair MJ; Deischinger C; Simonovska A; Widhalm G; Gatterbauer B; Dieckmann K; Heller G; Preusser M; Berghoff AS Br J Cancer; 2021 Mar; 124(7):1294-1300. PubMed ID: 33473170 [TBL] [Abstract][Full Text] [Related]
8. Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS. Yang J; Guo X; Wang M; Ma X; Ye X; Lin P Sci Rep; 2017 Dec; 7(1):17166. PubMed ID: 29215037 [TBL] [Abstract][Full Text] [Related]
9. [Relationship between preoperative inflammatory indexes and prognosis of patients with rectal cancer and establishment of prognostic nomogram prediction model]. Zhang L; Shi FY; Qin Q; Liu GX; Zhang HW; Yan J; Tan M; Wang LZ; Xue D; Hu CH; Zhang Z; She JJ Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):402-409. PubMed ID: 35615796 [No Abstract] [Full Text] [Related]
10. A High Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Advanced Gallbladder Cancer Receiving Chemotherapy. Choi YH; Lee JW; Lee SH; Choi JH; Kang J; Lee BS; Paik WH; Ryu JK; Kim YT Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1045-1051. PubMed ID: 30842131 [TBL] [Abstract][Full Text] [Related]
11. Diversity and heterogeneity of immune states in non-small cell lung cancer and small cell lung cancer. Rice SJ; Belani CP PLoS One; 2021; 16(12):e0260988. PubMed ID: 34855926 [TBL] [Abstract][Full Text] [Related]
12. Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte. Chen L; Zhang F; Sheng XG; Zhang SQ; Chen YT; Liu BW Medicine (Baltimore); 2016 Aug; 95(32):e4381. PubMed ID: 27512849 [TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Preoperative Systemic Immunoinflammatory Measures in Patients with Esophageal Cancer. Ishibashi Y; Tsujimoto H; Hiraki S; Kumano I; Yaguchi Y; Horiguchi H; Nomura S; Ito N; Shinto E; Aosasa S; Yamamoto J; Ueno H Ann Surg Oncol; 2018 Oct; 25(11):3288-3299. PubMed ID: 30019304 [TBL] [Abstract][Full Text] [Related]
14. Preoperative neutrophil-lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery. Zhang Y; Wang L; Liu Y; Wang S; Shang P; Gao Y; Chen X Int J Gynecol Cancer; 2014 Sep; 24(7):1319-25. PubMed ID: 25033256 [TBL] [Abstract][Full Text] [Related]
15. Pretreatment neutrophil-lymphocyte and platelet-lymphocyte ratio predict clinical outcome and prognosis for cervical Cancer. Zhu M; Feng M; He F; Han B; Ma K; Zeng X; Liu Z; Liu X; Li J; Cao H; Liang Y; Jia C; Zhang L Clin Chim Acta; 2018 Aug; 483():296-302. PubMed ID: 29758203 [TBL] [Abstract][Full Text] [Related]
16. Combination of Platelet-Lymphocyte Ratio and Monocyte-Lymphocyte Ratio as a New Promising Prognostic Factor in Upper Tract Urothelial Carcinoma With Large Tumor Sizes > 3 cm. Jan HC; Hu CY; Yang WH; Ou CH Clin Genitourin Cancer; 2020 Aug; 18(4):e484-e500. PubMed ID: 32199741 [TBL] [Abstract][Full Text] [Related]
17. The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study. Toyokawa T; Kubo N; Tamura T; Sakurai K; Amano R; Tanaka H; Muguruma K; Yashiro M; Hirakawa K; Ohira M BMC Cancer; 2016 Sep; 16(1):722. PubMed ID: 27599460 [TBL] [Abstract][Full Text] [Related]
18. Nomogram based on pre-treatment inflammatory biomarkers predicting survival in patients with head and neck soft tissue sarcoma. Chen L; Zeng H; Du Z; Zhao Y; Ma X Cancer Biomark; 2020; 29(1):151-161. PubMed ID: 32623392 [TBL] [Abstract][Full Text] [Related]
19. The predictive value of systemic immune inflammation index for postoperative survival of gallbladder carcinoma patients. Chen H; Huang Z; Sun B; Wang A; Wang Y; Shi H; Zheng T; Li T; Huang M; Fu W J Surg Oncol; 2021 Jul; 124(1):59-66. PubMed ID: 33765331 [TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of immune inflammation biomarkers in predicting survival and radiosensitivity in patients with non-small-cell lung cancer treated with chemoradiotherapy. Delikgoz Soykut E; Kemal Y; Karacin C; Karaoglanoglu O; Kurt M; Aytac Arslan S J Med Imaging Radiat Oncol; 2022 Feb; 66(1):146-157. PubMed ID: 34632714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]